留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

罕见乙肝病毒感染合并非肝脏合成功能障碍所致的胆碱酯酶极度降低2例个案报道并文献复习

柏保利 匡小林 胡明芬 常国楫 张露 李生浩 王晴晴

柏保利, 匡小林, 胡明芬, 常国楫, 张露, 李生浩, 王晴晴. 罕见乙肝病毒感染合并非肝脏合成功能障碍所致的胆碱酯酶极度降低2例个案报道并文献复习[J]. 昆明医科大学学报, 2023, 44(12): 59-64. doi: 10.12259/j.issn.2095-610X.S20231210
引用本文: 柏保利, 匡小林, 胡明芬, 常国楫, 张露, 李生浩, 王晴晴. 罕见乙肝病毒感染合并非肝脏合成功能障碍所致的胆碱酯酶极度降低2例个案报道并文献复习[J]. 昆明医科大学学报, 2023, 44(12): 59-64. doi: 10.12259/j.issn.2095-610X.S20231210
Baoli BAI, Xiaolin KUANG, Mingfen HU, Guoji CHANG, Lu ZHANG, Shenghao LI, Qingqing WANG. Rare Cases of Hepatitis B Virus Infection Combined with Severe Cholinesterase Deficiency not Caused by Liver Dysfunction: Two Case Reports and Literature Review[J]. Journal of Kunming Medical University, 2023, 44(12): 59-64. doi: 10.12259/j.issn.2095-610X.S20231210
Citation: Baoli BAI, Xiaolin KUANG, Mingfen HU, Guoji CHANG, Lu ZHANG, Shenghao LI, Qingqing WANG. Rare Cases of Hepatitis B Virus Infection Combined with Severe Cholinesterase Deficiency not Caused by Liver Dysfunction: Two Case Reports and Literature Review[J]. Journal of Kunming Medical University, 2023, 44(12): 59-64. doi: 10.12259/j.issn.2095-610X.S20231210

罕见乙肝病毒感染合并非肝脏合成功能障碍所致的胆碱酯酶极度降低2例个案报道并文献复习

doi: 10.12259/j.issn.2095-610X.S20231210
基金项目: 国家自然科学基金资助项目(82260408);云南省科技厅基础研究专项面上基金资助项目(202101AT070054);昆明市社会发展与科技惠民计划基金资助项目(2023-1-NS-002);昆明市卫健委卫生科研课题基金资助项目(2022-03-08-005;2022-03-08-011)
详细信息
    作者简介:

    柏保利(1982~),女,湖南祁阳人,医学硕士,主治医师,主要从事肝脏疾病临床诊治及研究工作

    匡小林与柏保利对本文有同等贡献

    通讯作者:

    李生浩,E-mail:doctorlee3h@163.com

    王晴晴,E-mail:wangqingqing1511@163.com

  • 中图分类号: R512.6+2

Rare Cases of Hepatitis B Virus Infection Combined with Severe Cholinesterase Deficiency not Caused by Liver Dysfunction: Two Case Reports and Literature Review

  • 摘要:   目的  分析乙肝病毒感染合并非肝脏合成功能障碍所致的胆碱酯酶(CHE)极度降低的罕见病例,探讨其临床意义。  方法  收集2021年7月和2022年2月在昆明市第三人民医院住院的2例罕见病例的临床资料,包括肝功能、凝血功能、乙肝标记物、乙肝病毒量、全外显子测序等进行分析,并作文献复习。  结果  2例乙肝病毒感染患者均长期CHE极度降低,肝脏合成功能良好,全外显子测序均显示存在血清胆碱酯酶(BCHE)基因突变。  结论  案例CHE极度低下并非是肝脏合成功能障碍所致。全外显子测序检出了2例患者的BCHE基因突变,非肝脏合成功能障碍所致的胆碱酯酶极度降低患者,进行BCHE基因突变筛查可能是必要的。
  • 图  1  病例1的全外显子测序及家系验证图谱

    BCHE基因发生2个突变,分别为NM_000055:exon2: c.1240C>T: p.Arg414Cys和NM_000055:exon2:c.401dup: p.Asn134LysfsTer24。蓝色阴影为发生基因突变的位点。

    Figure  1.  Whole exon sequencing and family verification of case 1

    图  2  人类BCHE基因图谱及常见的物种突变情况[5]

    Figure  2.  Human BCHE gene map and common species mutations

    表  1  病例2全外显子测序检出的BCHE基因突变情况

    Table  1.   BCHE gene mutations detected by whole exon sequencing in case 2

    基因(参考序列)变异染色体位置变异频率
    BCHE(NM_000055.2)c.1699G>A(p.A567T)纯合变异Chr3:1654912800.1137
    BCHE(NM_000055.2)c.1177G>C(p.G393R)杂合变异Chr3:1655476450.0017
    下载: 导出CSV
  • [1] 张明,李盾,陈仪本,等. 乙酰胆碱酯酶分子生物学研究进展[J]. 农药,2006,45(1):8-11. doi: 10.3969/j.issn.1006-0413.2006.01.003
    [2] Andersson M L,M Ller A M,Wildgaard K. Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: A systematic review[J]. Anaesthesia,2019,74(4):518-528. doi: 10.1111/anae.14545
    [3] Trujillo R, West W P. Pseudocholinesterase deficiency [M]. StatPearls. Treasure Island (FL); StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC. 2023: 5-8.
    [4] Arslan M,Novak M,Rosenthal D,et al. Cholinesterase deficiency syndrome-A pitfall in the use of butyrylcholinesterase as a biomarker for Wilson's disease[J]. Biomolecules,2022,12(10):1398. doi: 10.3390/biom12101398
    [5] Yen T,Nightingale B N,Burns J C,et al. Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population[J]. Clin Chem,2003,49(8):1297-1308. doi: 10.1373/49.8.1297
    [6] Stockhoff L,Muellner-Bucsics T,Markova A A,et al. Low serum cholinesterase identifies patients with worse outcome and increased mortality after TIPS[J]. Hepatology Communications,2022,6(3):621-632. doi: 10.1002/hep4.1829
    [7] Zivkovic A R,Schmidt K,Sigl A,et al. Reduced serum butyrylcholinesterase activity indicates severe systemic inflammation in critically ill patients[J]. Mediators of Inflammation,2015,2015(5):274607.
    [8] Decker S O,Kr Ger A,Wilk H,et al. Concurrent change in serum cholinesterase activity and midregional-proadrennomedullin level could predict patient outcome following liver transplantation[J]. Biomolecules,2022,12(7):989. doi: 10.3390/biom12070989
    [9] Geng H,Wang S,Jin Y,et al. Nutritional status and body composition in Wilson disease: A cross-sectional study from China[J]. Frontiers in nutrition,2021,8(6):790520.
    [10] Bhusal S,Bhandari R,Dahal S,et al. Organophosphorus poisoning among patients admitted to the intensive care unit of the department of internal medicine in a tertiary care centre: A descriptive cross-sectional study[J]. JNMA; Journal of the Nepal Medical Association,2022,60(253):766-769. doi: 10.31729/jnma.7823
    [11] Garmavy H M S,Mohammed A A,Rashid H M,et al. A meta-analysis of normal human blood cholinesterase activities determined by a modified electrometric method[J]. Journal of Medicine and Life,2023,16(1):22-34. doi: 10.25122/jml-2022-0215
    [12] Anglister N,Gonen-Shalom S,Shlanger P,et al. Plasma cholinesterase activity: A benchmark for rapid detection of pesticide poisoning in an avian scavenger[J]. The Science of the Total Environment,2023,877(6):162903.
    [13] 杜锴. 血浆凝血因子及胆碱酯酶在肝硬化患者的表达及临床意义[J]. 四川解剖学杂志,2020,28(4):62-63. doi: 10.3969/j.issn.1005-1457.2020.04.029
    [14] 孙志君. 胆碱酯酶活性检测对进行性肝硬化诊断的临床意义[J]. 中外医疗,2020,39(22):1-3. doi: 10.16662/j.cnki.1674-0742.2020.22.001
    [15] Cornelius B W,Jacobs T M. Pseudocholinesterase deficiency considerations: A case study[J]. Anesthesia Progress,2020,67(3):177-184. doi: 10.2344/anpr-67-03-16
    [16] Soliday F K,Conley Y P,Henker R. Pseudocholinesterase deficiency: a comprehensive review of genetic,acquired,and drug influences[J]. AANA Journal,2010,78(4):313-320.
    [17] Acharya S,Bhattarai S,Shrimanker I,et al. A prolonged paralysis with succinylcholine in pseudocholinesterase deficiency: An undesired effect[J]. QJM:Monthly Journal of the Association of Physicians,2022,115(8):547-548. doi: 10.1093/qjmed/hcac103
    [18] Maxwell J,Boothby A,Osborne R,et al. Prolonged paralysis after electroconvulsive therapy due to butyrylcholinesterase gene mutation[J]. Journal of Clinical Psychopharmacology,2021,41(5):610-611. doi: 10.1097/JCP.0000000000001423
    [19] Pradhan B K,Van Helmond N,Mitrev L V,et al. Hereditary pseudocholinesterase deficiency discovery after electroconvulsive therapy[J]. BMJ Case Reports,2021,14(1):154-159.
    [20] Yu R,Guo Y,Dan Y,et al. A novel mutation in the BCHE gene and phenotype identified in a child with low butyrylcholinesterase activity: A case report[J]. BMC Medical Genetics,2018,19(1):58. doi: 10.1186/s12881-018-0561-5
    [21] Yang X,Dang P,Liu W,et al. The role of butyrylcholinesterase in the regulation of cognitive dysfunction in minimal hepatic encephalopathy: A potential blood marker of disease evolution[J]. Frontiers in Neurology,2022,13(9):990997.
    [22] Douville N J,Kheterpal S,Engoren M,et al. Genetic mutations associated with susceptibility to perioperative complications in a longitudinal biorepository with integrated genomic and electronic health records[J]. British Journal of Anaesthesia,2020,125(6):986-994. doi: 10.1016/j.bja.2020.08.009
    [23] Kurnutala L N,Rugnath N. Pseudocholinesterase deficiency - Is succinylcholine still needed to facilitate endotracheal intubation?[J]. Cureus,2020,12(9):10721.
    [24] Muntoni S,Rojkind M,Muntoni S. Colchicine reduces procollagen III and increases pseudocholinesterase in chronic liver disease[J]. World Journal of Gastroenterology,2010,16(23):2889-2894. doi: 10.3748/wjg.v16.i23.2889
  • [1] 海燕, 美力班·吐尔逊, 阿仙姑·哈斯木.  Pin1通过调控脂质代谢关键酶影响宫颈癌细胞的增殖及凋亡, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230107
    [2] 罗巧, 石宏, 王绍波.  α7-烟碱乙酰胆碱受体在肺癌发生、发展及治疗中的作用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220226
    [3] 袁枫, 角述兰, 陈瑞, 向兵兵, 思永玉.  依托咪酯在不同程度烧伤患者体内的药代动力学, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210637
    [4] 郝立君, 徐丽秀, 李金秋, 马俊旗, 阿仙姑·哈斯木.  肽基脯氨酰同分异构酶(Pin1)对子宫颈癌细胞脂质代谢的作用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210111
    [5] 朱理佳, 马晓丹, 段江, 李檬, 黄永坤.  不同胎龄、不同出生体重新生儿的首次肝功能指标的差异性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210330
    [6] 朱菁菁, 钱金桥.  丙泊酚、依托咪酯用于无痛人工流产术的效果观察, 昆明医科大学学报.
    [7] 谢姆西凯麦尔·奥布力喀斯木, 吐尔逊娜依·艾海提, 杨和银.  急性心肌梗死患者应用阿替普酶联合丁苯酞治疗的疗效及对血清MYO、Periostin水平的影响, 昆明医科大学学报.
    [8] 冯国华, 林华, 普菁莹, 高丽辉, 李玲, 牛艳芬.  3,5,2’,4’-四羟基查尔酮对大鼠尿酸及PC12细胞嘌呤代谢酶的影响, 昆明医科大学学报.
    [9] 刘建红, 周冀波.  血清胆碱酯酶在老年慢性阻塞性肺疾病呼吸衰竭患者中的表达及其与呼吸衰竭的相关性, 昆明医科大学学报.
    [10] 李蓝江.  GPIHBP1基因rs142861814位点多态性与高甘油三酯血症的相关性, 昆明医科大学学报.
    [11] 田园.  羧酸酯酶在抗肿瘤药物研究中的作用, 昆明医科大学学报.
    [12] 戴转云.  氟比诺芬酯对老年患者气管插管应激反应的临床研究, 昆明医科大学学报.
    [13] 吴阳.  维生素A棕榈酸酯眼用凝胶治疗干眼症疗效观察, 昆明医科大学学报.
    [14] 沈红.  前列腺特异性膜抗原、α-甲基酰基辅酶A消旋酶在前列腺癌中的表达及其临床意义, 昆明医科大学学报.
    [15] 于萍.  沙丁胺醇在3,4 -二氯苯基异氰酸酯万古霉素手性柱上的对映体分离, 昆明医科大学学报.
    [16] 肖林.  射频靶点结合胶原酶治疗颈椎间盘突出症研究, 昆明医科大学学报.
    [17] 肖林.  射频靶点结合胶原酶治疗颈椎间盘突出症研究, 昆明医科大学学报.
    [18] 曾红静.  蛋氨酸补偿代谢途径及蛋氨酸酶抗肿瘤研究进展, 昆明医科大学学报.
    [19] 朱建文.  丙泊酚复合氯化琥珀酰胆碱在电休克治疗中的安全性, 昆明医科大学学报.
    [20] 木云珍.  树鼩全血胆碱酯酶活性测定分析, 昆明医科大学学报.
  • 加载中
图(2) / 表(1)
计量
  • 文章访问数:  644
  • HTML全文浏览量:  457
  • PDF下载量:  11
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-07-31
  • 网络出版日期:  2023-12-20
  • 刊出日期:  2023-12-25

目录

    /

    返回文章
    返回